ORMP
ORMP
NASDAQ · Pharmaceuticals

Oramed Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$3.50
+0.08 (+2.34%)
As of Mar 25, 10:07 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +172.9% upside
Low Target $5.95
Average Target $9.55
High Target $10.69
Current Price $3.50
Current
$3.50
Target
$9.55
$5.95 $9.55 avg $10.69
Scenario Analysis
Bear Case
$5.95
70.0%
Low target
Base Case
$9.55
+172.9%
Avg target
Bull Case
$10.69
+205.4%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$3.76
-6.9% from high
52-Week Low
$1.82
+92.3% from low
Target vs 52W High
$9.55
+154.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%